ORPHA:770
Rabies
Publications
54,039
98.8th percentile
Trials
103
Interventional, condition-specific
Researchers
1,317
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Rabies is a viral zoonosis leading to a fatal if not treated.
How rare: 1-9 / 1 000 000 — roughly one to nine people per million. In a city the size of Kolkata, perhaps a few dozen.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019173
- MeSH:D011818
- UMLS:C0034494
- NCIT:C28182
Additional Mondo synonyms (1)
lyssa
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
54,039 matched papers (22,722 in last 10 years) Source
- Phenotype characterisedPresent
23 HPO annotations (e.g. Fever; Migraine; Reduced consciousness) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
103 matched on ClinicalTrials.gov (13 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
23
Associated phenotypes · MONDO:0019173
- Fever
- Migraine
- Reduced consciousness
- Cerebral palsy
- Vocal cord paresis
Showing 5 of 23 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
1 associated chemical. Therapeutic evidence is listed first when present — not a treatment recommendation.
- cinnabarin · therapeutic
Literature
Is anyone studying this?
54,039
54,039 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
54,039 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
22,722 in the last 10 years · medium confidence · 98.8th percentile (publications denominator)
Phrase hits: 54,039 · MeSH hits: 0
Who's working on it?
1,317
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Hampson K6 papers · 2026
School of Biodiversity, One Health & Veterinary Medicine, , ,
Papers in Europe PMC - 02Gupta S5 papers · 2026
Department of Neurovirology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India.
Papers in Europe PMC - 03Mani RS5 papers · 2026
Department of Neurovirology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Electronic address: drreeta@gmail.com.
Papers in Europe PMC - 04Müller T5 papers · 2026
Institute of Molecular Virology and Cell Biology (WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems ,
Papers in Europe PMC - 05Rupprecht CE5 papers · 2026
College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA.
Papers in Europe PMC - 06Ashwini MA4 papers · 2026
Department of Neurovirology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India.
Papers in Europe PMC - 07Liu X4 papers · 2026
College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Papers in Europe PMC - 08Lodha L4 papers · 2026
Department of Neurovirology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India.
Papers in Europe PMC - 09Ma Y4 papers · 2026
The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Papers in Europe PMC - 10Wallace RM4 papers · 2026
Poxvirus and Rabies Branch, US Centers for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
103
interventional trials for this specific condition
103 interventional trials matched this specific condition name; 13 currently recruiting in our sample.
Data as of 11 September 2026
103 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 98.6th percentile).
medium confidence · 98.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
103 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07021703·RECRUITING·A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried
Not reviewed·Conditions: Rabies·Matched via name phrase
- NCT07055880·NOT YET RECRUITING·Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)
Not reviewed·Conditions: Rabies·Matched via name phrase
- NCT07345208·NOT YET RECRUITING·Safety and Immunogenicity of ID vs IM Rabies Vaccine
Not reviewed·Conditions: Rabies·Matched via name phrase
- NCT06548139·NOT YET RECRUITING·Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials
Not reviewed·Conditions: Rabies Virus Infection·Matched via name phrase
- NCT07055893·NOT YET RECRUITING·Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen
Not reviewed·Conditions: Rabies (Healthy Volunteers)·Matched via name phrase
- NCT07055295·NOT YET RECRUITING·Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen
Not reviewed·Conditions: Rabies·Matched via name phrase
- NCT05545371·ENROLLING BY INVITATION·Prevention of Rabies With Four Doses of Rabies Vaccine
Not reviewed·Conditions: Rabies Human · Antibody·Matched via name phrase
- NCT07416110·NOT YET RECRUITING·Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine
Not reviewed·Conditions: Rabies (Healthy Volunteers)·Matched via name phrase
- NCT07445815·NOT YET RECRUITING·A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody
Not reviewed·Conditions: Rabies (Healthy Volunteers)·Matched via name phrase
- NCT07168018·NOT YET RECRUITING·Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine
Not reviewed·Conditions: Rabies·Matched via name phrase
- NCT07455318·NOT YET RECRUITING·Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.
Not reviewed·Conditions: Rabies (Healthy Volunteers)·Matched via name phrase
- NCT07028801·NOT YET RECRUITING·Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)
Not reviewed·Conditions: Rabies·Matched via name phrase
- NCT07500207·ENROLLING BY INVITATION·A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)
Not reviewed·Conditions: Rabies Prevention·Matched via name phrase
Observational and natural-history studies
8 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07120464·RECRUITING·Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
Not reviewed·Conditions: Rabies Exposure · Immunocompromised · Chronic Disease·Matched via name phrase
- NCT07327307·RECRUITING·Real World Evidence Study of SYN023 in Children Exposed to Rabies
Not reviewed·Conditions: Rabies Post-exposure Prophylaxis·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 23 · after dedupe 22 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 22 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (22)
- ctis·2025-524765-24-00·Authorised·A multicentre, open-label trial in healthy volunteers to assess the boostability of three different rabies pre-exposure prophylaxis regimens when administering a single-dose, intramuscular vaccination as simulated post-exposure prophylaxis at least five years following priming. "BAZOOKA_221"
skipped — LLM skipped (--skip-llm)
- ctis·2024-515122-89-00·Authorised, ongoing·An open-label pilot study to assess pain experience and usability of different injection techniques and devices for the administration of the purified chick-embryo cell-culture rabies vaccine in children aged 4 to 14 years
skipped — LLM skipped (--skip-llm)
- ctis·2023-510480-35-00·Authorised, ongoing·SIRAVA: Five-year boostability after single-visit single-dose intramuscular rabies pre-exposure prophylaxis
skipped — LLM skipped (--skip-llm)
- ctis·2024-511194-29-00·Cancelled·A Phase I, randomized, double-blind, multi-centre, placebo-controlled, dose-escalation study to evaluate the safety, reactogenicity and immunogenicity of AstriVax’ investigational vaccine for the prevention of yellow fever (AVX70120), and of AstriVax’ investigational vaccine for the prevention of rabies (AVX70481), in healthy adults aged 18 to 40 years.
skipped — LLM skipped (--skip-llm)
- ctis·2024-511506-22-00·Cancelled·A two-centre open-label non-inferiority trial to assess the immunogenicity and safety of an intradermal and an intramuscular single-visit dosing regimen of purified chick-embryo cell-culture rabies vaccine in adults
skipped — LLM skipped (--skip-llm)
- ctis·2023-507065-26-00·Cancelled·A randomized controlled trial to compare the immunogenicity and skin imprinting of intradermal and intramuscular rabies vaccination < RABISKIMM >
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN91975924·Recruiting·A clinical trial to assess whether a self-amplifying ribonucleic acid (saRNA) vaccine against Rabies viruses is safe and induces immune responses
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11357259·Recruiting·An early safety study testing a drug combination given before possible surgery for people with pancreatic cancer that can’t be easily removed yet or hasn’t spread far
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16573769·No longer recruiting·DOMENICA: Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus dostarlimab in a first-line advanced/metastatic setting
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12751107·Recruiting·Adding male single-dose HPV vaccination to female HPV vaccination in Tanzania
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15021247·No longer recruiting·Phase II study for the treatment of recurrent and/or metastatic human papillomavirus (HPV16)-associated head and neck cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13649456·No longer recruiting·A study of three malaria vaccines to prevent the transmission of malaria in adults in Mali: TBVax2
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN80472712·No longer recruiting·Testing IMM60 in combination with pembrolizumab in melanoma and non-small cell lung cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN47448832·No longer recruiting·Evaluating the safety and immune response to RH5 blood-stage malaria vaccine in adults, young children and infants living in Tanzania
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14813279·No longer recruiting·Comparing two strategies for the mass vaccination of dogs to prevent rabies in humans
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN95900287·No longer recruiting·A trial to see the effect of cyclophosphamide and pembrolizumab on cancer in the kidney that has spread further into the body
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN65689096·No longer recruiting·Comparison of two techniques for collecting umbilical cord blood: on the mother (upper level) versus on the delivery table (bottom level)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12693237·No longer recruiting·A phase Ib study to assess safety and tolerability and neutralising activity of CL184 in healthy volunteers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN67270384·No longer recruiting·Therapeutic vaccination for chronic hepatitis B virus infection in Africa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN88335123·No longer recruiting·Safety, immunogenicity and efficacy against febrile malaria of the candidate vaccines FP9 ME-TRAP and MVA ME-TRAP for children in an endemic area
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN30087513·No longer recruiting·Research to improve economical anti-rabies treatment
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN05221133·No longer recruiting·Randomised controlled double-blind trial of DNA ME-TRAP/MVA ME-TRAP against malaria infection in Gambians aged 15 to 45
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Rabies — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Rabies" OR "lyssa"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Rabies" OR "lyssa"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 103 interventional · 8 observational · 1 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T15:17:45.895Z
